世界のエルロチニブ塩酸塩市場2020:製造業者別、地域別、種類・用途別

【英語タイトル】Global Erlotinib Hydrochloride Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20AG08414)・商品コード:GIR20AG08414
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年7月
・ページ数:104
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:材料・化学物質
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥365,400見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥548,100見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、エルロチニブ塩酸塩の世界市場を広く調査・分析し、今後の市場展望をまとめております。エルロチニブ塩酸塩の種類別市場規模(25mg錠、100mg錠、150mg錠)、用途別市場規模(非小細胞肺がん(NSCLC)、膵臓がん、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):HEC Pharm、Shanghai Biosundrug Co., Ltd.、Polpharma Pharmaceutical Works、Arasto Pharmaceutical Chemicals Inc.、Tecoland、Tava、Natco Pharma、Suanfarma、Shilpa Medicare Ltd.
・地域別グローバル市場分析 2015年-2020年
・エルロチニブ塩酸塩の北米市場(アメリカ、カナダ、メキシコ)
・エルロチニブ塩酸塩のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・エルロチニブ塩酸塩のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・エルロチニブ塩酸塩の南米市場(ブラジル、アルゼンチン)
・エルロチニブ塩酸塩の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:25mg錠、100mg錠、150mg錠
・用途別分析:非小細胞肺がん(NSCLC)、膵臓がん、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Erlotinib Hydrochloride market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Erlotinib Hydrochloride market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Erlotinib Hydrochloride market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Erlotinib Hydrochloride market has been segmented into
25 mg tablet
100 mg tablet
150 mg tablet

By Application, Erlotinib Hydrochloride has been segmented into:
Non-Small Cell Lung Cancer (NSCLC)
Pancreatic Cancer
Other Types of Cancer

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Erlotinib Hydrochloride market presented in the report. This section sheds light on the sales growth of different regional and country-level Erlotinib Hydrochloride markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Erlotinib Hydrochloride market.

The report offers in-depth assessment of the growth and other aspects of the Erlotinib Hydrochloride market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Erlotinib Hydrochloride Market Share Analysis
Erlotinib Hydrochloride competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Erlotinib Hydrochloride sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Erlotinib Hydrochloride sales, revenue and market share for each player covered in this report.

The major players covered in Erlotinib Hydrochloride are:
HEC Pharm
Shanghai Biosundrug Co., Ltd.
Polpharma Pharmaceutical Works
Arasto Pharmaceutical Chemicals Inc.
Tecoland
Tava
Natco Pharma
Suanfarma
Shilpa Medicare Ltd.

Among other players domestic and global, Erlotinib Hydrochloride market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Erlotinib Hydrochloride product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Erlotinib Hydrochloride, with price, sales, revenue and global market share of Erlotinib Hydrochloride in 2018 and 2019.
Chapter 3, the Erlotinib Hydrochloride competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Erlotinib Hydrochloride breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Erlotinib Hydrochloride market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Erlotinib Hydrochloride sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Erlotinib Hydrochloride Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Erlotinib Hydrochloride Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 25 mg tablet
1.2.3 100 mg tablet
1.2.4 150 mg tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Erlotinib Hydrochloride Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Non-Small Cell Lung Cancer (NSCLC)
1.3.3 Pancreatic Cancer
1.3.4 Other Types of Cancer
1.4 Overview of Global Erlotinib Hydrochloride Market
1.4.1 Global Erlotinib Hydrochloride Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 HEC Pharm
2.1.1 HEC Pharm Details
2.1.2 HEC Pharm Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 HEC Pharm SWOT Analysis
2.1.4 HEC Pharm Product and Services
2.1.5 HEC Pharm Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Shanghai Biosundrug Co., Ltd.
2.2.1 Shanghai Biosundrug Co., Ltd. Details
2.2.2 Shanghai Biosundrug Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Shanghai Biosundrug Co., Ltd. SWOT Analysis
2.2.4 Shanghai Biosundrug Co., Ltd. Product and Services
2.2.5 Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Polpharma Pharmaceutical Works
2.3.1 Polpharma Pharmaceutical Works Details
2.3.2 Polpharma Pharmaceutical Works Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Polpharma Pharmaceutical Works SWOT Analysis
2.3.4 Polpharma Pharmaceutical Works Product and Services
2.3.5 Polpharma Pharmaceutical Works Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Arasto Pharmaceutical Chemicals Inc.
2.4.1 Arasto Pharmaceutical Chemicals Inc. Details
2.4.2 Arasto Pharmaceutical Chemicals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Arasto Pharmaceutical Chemicals Inc. SWOT Analysis
2.4.4 Arasto Pharmaceutical Chemicals Inc. Product and Services
2.4.5 Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Tecoland
2.5.1 Tecoland Details
2.5.2 Tecoland Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Tecoland SWOT Analysis
2.5.4 Tecoland Product and Services
2.5.5 Tecoland Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Tava
2.6.1 Tava Details
2.6.2 Tava Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Tava SWOT Analysis
2.6.4 Tava Product and Services
2.6.5 Tava Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Natco Pharma
2.7.1 Natco Pharma Details
2.7.2 Natco Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Natco Pharma SWOT Analysis
2.7.4 Natco Pharma Product and Services
2.7.5 Natco Pharma Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Suanfarma
2.8.1 Suanfarma Details
2.8.2 Suanfarma Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Suanfarma SWOT Analysis
2.8.4 Suanfarma Product and Services
2.8.5 Suanfarma Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Shilpa Medicare Ltd.
2.9.1 Shilpa Medicare Ltd. Details
2.9.2 Shilpa Medicare Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Shilpa Medicare Ltd. SWOT Analysis
2.9.4 Shilpa Medicare Ltd. Product and Services
2.9.5 Shilpa Medicare Ltd. Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Erlotinib Hydrochloride Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Erlotinib Hydrochloride Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Erlotinib Hydrochloride Manufacturer Market Share in 2019
3.3.2 Top 6 Erlotinib Hydrochloride Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Erlotinib Hydrochloride Sales, Revenue and Market Share by Regions
4.1.1 Global Erlotinib Hydrochloride Sales and Market Share by Regions (2015-2020)
4.1.2 Global Erlotinib Hydrochloride Revenue and Market Share by Regions (2015-2020)
4.2 North America Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
4.3 Europe Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
4.5 South America Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Erlotinib Hydrochloride Sales, Revenue and Market Share by Country
5.1.1 North America Erlotinib Hydrochloride Sales and Market Share by Country (2015-2020)
5.1.2 North America Erlotinib Hydrochloride Revenue and Market Share by Country (2015-2020)
5.2 United States Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
5.3 Canada Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
5.4 Mexico Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Erlotinib Hydrochloride Sales, Revenue and Market Share by Country
6.1.1 Europe Erlotinib Hydrochloride Sales and Market Share by Country (2015-2020)
6.1.2 Europe Erlotinib Hydrochloride Revenue and Market Share by Country (2015-2020)
6.2 Germany Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
6.3 UK Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
6.4 France Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
6.5 Russia Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
6.6 Italy Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Erlotinib Hydrochloride Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Erlotinib Hydrochloride Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Erlotinib Hydrochloride Revenue and Market Share by Regions (2015-2020)
7.2 China Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
7.3 Japan Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
7.4 Korea Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
7.5 India Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
7.7 Australia Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Erlotinib Hydrochloride Sales, Revenue and Market Share by Country
8.1.1 South America Erlotinib Hydrochloride Sales and Market Share by Country (2015-2020)
8.1.2 South America Erlotinib Hydrochloride Revenue and Market Share by Country (2015-2020)
8.2 Brazil Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
8.3 Argentina Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Erlotinib Hydrochloride Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Erlotinib Hydrochloride Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Erlotinib Hydrochloride Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
9.3 Turkey Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
9.4 Egypt Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
9.5 South Africa Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Erlotinib Hydrochloride Sales and Market Share by Type (2015-2020)
10.2 Global Erlotinib Hydrochloride Revenue and Market Share by Type (2015-2020)
10.3 Global Erlotinib Hydrochloride Price by Type (2015-2020)
11 Global Erlotinib Hydrochloride Market Segment by Application
11.1 Global Erlotinib Hydrochloride Sales Market Share by Application (2015-2020)
11.2 Global Erlotinib Hydrochloride Revenue Market Share by Application (2015-2020)
11.3 Global Erlotinib Hydrochloride Price by Application (2015-2020)
12 Market Forecast
12.1 Global Erlotinib Hydrochloride Sales, Revenue and Growth Rate (2021-2025)
12.2 Erlotinib Hydrochloride Market Forecast by Regions (2021-2025)
12.2.1 North America Erlotinib Hydrochloride Market Forecast (2021-2025)
12.2.2 Europe Erlotinib Hydrochloride Market Forecast (2021-2025)
12.2.3 Asia-Pacific Erlotinib Hydrochloride Market Forecast (2021-2025)
12.2.4 South America Erlotinib Hydrochloride Market Forecast (2021-2025)
12.2.5 Middle East & Africa Erlotinib Hydrochloride Market Forecast (2021-2025)
12.3 Erlotinib Hydrochloride Market Forecast by Type (2021-2025)
12.3.1 Global Erlotinib Hydrochloride Sales Forecast by Type (2021-2025)
12.3.2 Global Erlotinib Hydrochloride Market Share Forecast by Type (2021-2025)
12.4 Erlotinib Hydrochloride Market Forecast by Application (2021-2025)
12.4.1 Global Erlotinib Hydrochloride Sales Forecast by Application (2021-2025)
12.4.2 Global Erlotinib Hydrochloride Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Erlotinib Hydrochloride Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Erlotinib Hydrochloride by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Erlotinib Hydrochloride Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. HEC Pharm Basic Information, Manufacturing Base and Competitors
Table 8. HEC Pharm Erlotinib Hydrochloride Major Business
Table 9. HEC Pharm Erlotinib Hydrochloride Total Revenue (USD Million) (2018-2019)
Table 10. HEC Pharm SWOT Analysis
Table 11. HEC Pharm Erlotinib Hydrochloride Product and Services
Table 12. HEC Pharm Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Shanghai Biosundrug Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Major Business
Table 15. Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Total Revenue (USD Million) (2018-2019)
Table 16. Shanghai Biosundrug Co., Ltd. SWOT Analysis
Table 17. Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Product and Services
Table 18. Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Polpharma Pharmaceutical Works Basic Information, Manufacturing Base and Competitors
Table 20. Polpharma Pharmaceutical Works Erlotinib Hydrochloride Major Business
Table 21. Polpharma Pharmaceutical Works Erlotinib Hydrochloride Total Revenue (USD Million) (2018-2019)
Table 22. Polpharma Pharmaceutical Works SWOT Analysis
Table 23. Polpharma Pharmaceutical Works Erlotinib Hydrochloride Product and Services
Table 24. Polpharma Pharmaceutical Works Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Arasto Pharmaceutical Chemicals Inc. Basic Information, Manufacturing Base and Competitors
Table 26. Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Major Business
Table 27. Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Total Revenue (USD Million) (2018-2019)
Table 28. Arasto Pharmaceutical Chemicals Inc. SWOT Analysis
Table 29. Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Product and Services
Table 30. Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Tecoland Basic Information, Manufacturing Base and Competitors
Table 32. Tecoland Erlotinib Hydrochloride Major Business
Table 33. Tecoland Erlotinib Hydrochloride Total Revenue (USD Million) (2018-2019)
Table 34. Tecoland SWOT Analysis
Table 35. Tecoland Erlotinib Hydrochloride Product and Services
Table 36. Tecoland Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Tava Basic Information, Manufacturing Base and Competitors
Table 38. Tava Erlotinib Hydrochloride Major Business
Table 39. Tava Erlotinib Hydrochloride Total Revenue (USD Million) (2018-2019)
Table 40. Tava SWOT Analysis
Table 41. Tava Erlotinib Hydrochloride Product and Services
Table 42. Tava Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Natco Pharma Erlotinib Hydrochloride Major Business
Table 45. Natco Pharma Erlotinib Hydrochloride Total Revenue (USD Million) (2018-2019)
Table 46. Natco Pharma SWOT Analysis
Table 47. Natco Pharma Erlotinib Hydrochloride Product and Services
Table 48. Natco Pharma Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Suanfarma Basic Information, Manufacturing Base and Competitors
Table 50. Suanfarma Erlotinib Hydrochloride Major Business
Table 51. Suanfarma Erlotinib Hydrochloride Total Revenue (USD Million) (2018-2019)
Table 52. Suanfarma SWOT Analysis
Table 53. Suanfarma Erlotinib Hydrochloride Product and Services
Table 54. Suanfarma Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Shilpa Medicare Ltd. Basic Information, Manufacturing Base and Competitors
Table 56. Shilpa Medicare Ltd. Erlotinib Hydrochloride Major Business
Table 57. Shilpa Medicare Ltd. Erlotinib Hydrochloride Total Revenue (USD Million) (2018-2019)
Table 58. Shilpa Medicare Ltd. SWOT Analysis
Table 59. Shilpa Medicare Ltd. Erlotinib Hydrochloride Product and Services
Table 60. Shilpa Medicare Ltd. Erlotinib Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Erlotinib Hydrochloride Sales by Manufacturer (2018-2019) (K MT)
Table 62. Global Erlotinib Hydrochloride Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Erlotinib Hydrochloride Sales by Regions (2015-2020) (K MT)
Table 64. Global Erlotinib Hydrochloride Sales Market Share by Regions (2015-2020)
Table 65. Global Erlotinib Hydrochloride Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Erlotinib Hydrochloride Sales by Countries (2015-2020) (K MT)
Table 67. North America Erlotinib Hydrochloride Sales Market Share by Countries (2015-2020)
Table 68. North America Erlotinib Hydrochloride Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Erlotinib Hydrochloride Revenue Market Share by Countries (2015-2020)
Table 70. Europe Erlotinib Hydrochloride Sales by Countries (2015-2020) (K MT)
Table 71. Europe Erlotinib Hydrochloride Sales Market Share by Countries (2015-2020)
Table 72. Europe Erlotinib Hydrochloride Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Erlotinib Hydrochloride Sales by Regions (2015-2020) (K MT)
Table 74. Asia-Pacific Erlotinib Hydrochloride Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Erlotinib Hydrochloride Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Erlotinib Hydrochloride Sales by Countries (2015-2020) (K MT)
Table 77. South America Erlotinib Hydrochloride Sales Market Share by Countries (2015-2020)
Table 78. South America Erlotinib Hydrochloride Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Erlotinib Hydrochloride Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Erlotinib Hydrochloride Sales by Countries (2015-2020) (K MT)
Table 81. Middle East & Africa Erlotinib Hydrochloride Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Erlotinib Hydrochloride Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Erlotinib Hydrochloride Revenue Market Share by Countries (2015-2020)
Table 84. Global Erlotinib Hydrochloride Sales by Type (2015-2020) (K MT)
Table 85. Global Erlotinib Hydrochloride Sales Share by Type (2015-2020)
Table 86. Global Erlotinib Hydrochloride Revenue by Type (2015-2020) (USD Million)
Table 87. Global Erlotinib Hydrochloride Revenue Share by Type (2015-2020)
Table 88. Global Erlotinib Hydrochloride Sales by Application (2015-2020) (K MT)
Table 89. Global Erlotinib Hydrochloride Sales Share by Application (2015-2020)
Table 90. Global Erlotinib Hydrochloride Sales Forecast by Regions (2021-2025) (K MT)
Table 91. Global Erlotinib Hydrochloride Market Share Forecast by Regions (2021-2025)
Table 92. Global Erlotinib Hydrochloride Sales Forecast by Type (2021-2025) (K MT)
Table 93. Global Erlotinib Hydrochloride Market Share Forecast by Type (2021-2025)
Table 94. Global Erlotinib Hydrochloride Sales Forecast by Application (2021-2025)
Table 95. Global Erlotinib Hydrochloride Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Erlotinib Hydrochloride Picture
Figure 2. Global Sales Market Share of Erlotinib Hydrochloride by Type in 2019
Figure 3. 25 mg tablet Picture
Figure 4. 100 mg tablet Picture
Figure 5. 150 mg tablet Picture
Figure 6. Erlotinib Hydrochloride Sales Market Share by Application in 2018
Figure 7. Non-Small Cell Lung Cancer (NSCLC) Picture
Figure 8. Pancreatic Cancer Picture
Figure 9. Other Types of Cancer Picture
Figure 10. Global Erlotinib Hydrochloride Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Erlotinib Hydrochloride Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Erlotinib Hydrochloride Sales Market Share by Manufacturer in 2019
Figure 31. Global Erlotinib Hydrochloride Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Erlotinib Hydrochloride Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Erlotinib Hydrochloride Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 36. Global Erlotinib Hydrochloride Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Erlotinib Hydrochloride Revenue Market Share by Regions (2015-2020)
Figure 38. Global Erlotinib Hydrochloride Revenue Market Share by Regions in 2018
Figure 39. North America Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
Figure 40. Europe Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
Figure 42. South America Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Erlotinib Hydrochloride Sales and Growth Rate (2015-2020)
Figure 44. North America Erlotinib Hydrochloride Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Erlotinib Hydrochloride Sales Market Share by Countries (2015-2020)
Figure 46. North America Erlotinib Hydrochloride Sales Market Share by Countries in 2018
Figure 47. North America Erlotinib Hydrochloride Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Erlotinib Hydrochloride Revenue Market Share by Countries in 2018
Figure 49. United States Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Canada Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Mexico Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Europe Erlotinib Hydrochloride Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Erlotinib Hydrochloride Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Erlotinib Hydrochloride Revenue Market Share by Countries in 2019
Figure 55. Germany Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 56. UK Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 57. France Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Russia Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Italy Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Asia-Pacific Erlotinib Hydrochloride Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Erlotinib Hydrochloride Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Erlotinib Hydrochloride Revenue Market Share by Regions 2019
Figure 63. China Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Japan Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Korea Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 66. India Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Southeast Asia Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 68. South America Erlotinib Hydrochloride Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Erlotinib Hydrochloride Sales Market Share by Countries in 2019
Figure 70. South America Erlotinib Hydrochloride Revenue Market Share by Countries in 2019
Figure 71. Brazil Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Argentina Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Middle East and Africa Erlotinib Hydrochloride Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Erlotinib Hydrochloride Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Erlotinib Hydrochloride Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Erlotinib Hydrochloride Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Egypt Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Turkey Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 80. South Africa Erlotinib Hydrochloride Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Global Erlotinib Hydrochloride Sales and Growth Rate (2021-2025) (K MT)
Figure 82. Global Erlotinib Hydrochloride Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Erlotinib Hydrochloride Market Forecast (2021-2025) (K MT)
Figure 84. Europe Sales Erlotinib Hydrochloride Market Forecast (2021-2025) (K MT)
Figure 85. Asia-Pacific Sales Erlotinib Hydrochloride Market Forecast (2021-2025) (K MT)
Figure 86. South America Sales Erlotinib Hydrochloride Market Forecast (2021-2025) (K MT)
Figure 87. Middle East & Africa Sales Erlotinib Hydrochloride Market Forecast (2021-2025) (K MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel


★調査レポート[世界のエルロチニブ塩酸塩市場2020:製造業者別、地域別、種類・用途別] (コード:GIR20AG08414)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のエルロチニブ塩酸塩市場2020:製造業者別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆